OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers (Q56797813)

From Wikidata
Jump to navigation Jump to search
article
edit
Language Label Description Also known as
English
OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers
article

    Statements

    OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers (English)
    0 references
    S Vasan
    0 references
    A Hurley
    0 references
    SJ Schlesinger
    0 references
    D Hannaman
    0 references
    DF Gardiner
    0 references
    DP Dugin
    0 references
    MM Boente-Carrera
    0 references
    RM Vittorino
    0 references
    J Andersen
    0 references
    Y Huang
    0 references
    J Cox
    0 references
    T Tarragona
    0 references
    DK Gill
    0 references
    H Cheeseman
    0 references
    L Clark
    0 references
    L Dally
    0 references
    C Smith
    0 references
    C Schmidt
    0 references
    H Park
    0 references
    E Sayeed
    0 references
    J Gilmour
    0 references
    P Fast
    0 references
    R Bernard
    0 references
    DD Ho
    0 references
    2009
    0 references
    6
    0 references
    Suppl 3
    0 references
    O31
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit